Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Coeptis Therapeutics Holdings (COEP) Profit After Tax (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Profit After Tax data on record, last reported at -$2.9 million in Q3 2025.

  • For Q3 2025, Profit After Tax fell 58.5% year-over-year to -$2.9 million; the TTM value through Sep 2025 reached -$12.6 million, down 230.66%, while the annual FY2024 figure was -$9.8 million, N/A changed from the prior year.
  • Profit After Tax reached -$2.9 million in Q3 2025 per COEP's latest filing, up from -$4.3 million in the prior quarter.
  • Across five years, Profit After Tax topped out at $17.5 million in Q4 2023 and bottomed at -$29.9 million in Q4 2021.
  • Average Profit After Tax over 5 years is -$3.5 million, with a median of -$3.0 million recorded in 2024.
  • The widest YoY moves for Profit After Tax: up 695.01% in 2023, down 1981.4% in 2023.
  • A 5-year view of Profit After Tax shows it stood at -$29.9 million in 2021, then soared by 90.16% to -$2.9 million in 2022, then skyrocketed by 695.01% to $17.5 million in 2023, then crashed by 111.12% to -$1.9 million in 2024, then plummeted by 48.81% to -$2.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Profit After Tax were -$2.9 million in Q3 2025, -$4.3 million in Q2 2025, and -$3.4 million in Q1 2025.